Dr Patricia Kyprianidou has bachelor’s degree in chemistry, master’s degree in environmental engineering/industrial systems management and a doctorate in inorganic chemistry, in the area of radiopharmaceutical chemistry. She is a research functional scientist B’ at the Institute of Nuclear and Radiological Sciences and Technology, Energy and Safety, of the National Centre for Scientific Research “Demokritos” taking part in the Radiopharmaceutical Chemistry group, where she has been working since 1996.
Her research interests are focused on design, synthesis and characterization of novel compounds (peptides and small organic molecules) radiolabeled with β or γ emitters (99mTc, 186/188Re, 18F, 68Ga), as well as on their biological evaluation as potential radiopharmaceuticals for targeted diagnosis or therapy of various diseases.
She has participated in numerous R&D and technology transfer projects on radiopharmaceuticals, coordinated within the framework of the Radioisotopes and Radiopharmaceuticals Laboratory for the development of many radiopharmaceuticals over the years.
She has published 12 peer-reviewed publications in scientific journals and conferences and participated in several competitive funding research projects. She has contributed to the education and training of several young scientists from Greece and abroad, as well as of IAEA-granted scientists.
She has also a long professional experience in the private sector and particularly in the pharmaceutical industry, in analytical techniques and the pharmaceutical R&D, in posts of high responsibility.
From 2010 to 2014 she has been elected member of the Board of Directors of NCSR “Demokritos”.
Since late 2016 and until July 2019, she was appointed the Secretary General for Research and Technology of the Hellenic Ministry of Education, Research and Religious Affairs.
